You can quote several words to match them as a full term:
"some text to search"
otherwise, the single words will be understood as distinct search terms.
ANY of the entered words would match

Donald Rumsfeld’s hidden role in the development of Moderna’s covid injection

The covid and SARS pandemics were deliberately released from laboratories at the behest of pharmaceutical giants and governments, with the goal of profiting from the sale of vaccines and treatments. Donald Rumsfeld, a former US Secretary of

Donald Rumsfeld’s hidden role in the development of Moderna’s covid injection

The covid and SARS pandemics were deliberately released from laboratories at the behest of pharmaceutical giants and governments, with the goal of profiting from the sale of vaccines and treatments.

Donald Rumsfeld, a former US Secretary of Defence, is identified as a key figure in this scheme, with ties to pharmaceutical companies such as Gilead Sciences and Searle Pharmaceuticals.

Rumsfeld’s connections to these companies and his role in shaping US policy on bio-defence and pandemic preparedness provide evidence of a corrupt system in which pharmaceutical giants and governments collaborate to engineer viral problems and peddle therapeutic solutions for profit.

Pharmaceutical companies and financial institutions have profited significantly from the covid pandemic, with Rumsfeld’s business model of “create the problem, then profit from the solution” being present throughout.

Let’s not lose touch…Your Government and Big Tech are actively trying to censor the information reported by The Exposé to serve their own needs. Subscribe now to make sure you receive the latest uncensored news in your inbox…

Stay Updated!

Stay connected with News updates by Email

By Maria Lehrer

Like countless others, I’ve been obsessed with the mystery of where covid truly originated. As a troubleshooter, I couldn’t resist jumping into the heated debate over its origins. Instead of following the well-trodden paths of lab leaks and wet markets, I wanted to take a different angle: an unseen “hand of capital” that is pulling the strings behind the scenes.

Over the past few years, I’ve sifted through an overwhelming number of articles, research papers and government reports about this topic. The deeper I dug, the clearer the answer began to emerge. After piecing all these details together, I uncovered something more interesting and closer to the truth. I contended that the two global pandemics of the 21st century, namely, SARS and covid-19, were deliberately released from laboratories at the behest of pharmaceutical giants and governments.

Thus emerged a fraudulent recombinant coronavirus industry that capitalised on human lives. The mechanism operates as follows: Pharmaceutical giants (e.g. Gilead, Moderna, Pfizer) propped up politicians to positions of power. These captured officials then enable pharmaceutical giants to simultaneously engineer viral problems and peddle therapeutic solutions. After amassing obscene profits, these corporations reinvest in political patronage to perpetuate their interests, ultimately forming a closed-loop Möbius strip of corruption.

Table of Contents

  1. Spokesman of Pharmaceutical Giants: Donald H. Rumsfeld[1]
  2. Lucrative Business Opportunities
  3. Bypassing Regulations
  4. Breaking Bad: Ralph S. Baric
  5. Money-Grabber
  6. The Seeds of Corruption
  7. Alliance of the Greedy
  8. Pharmaceutical Giants Join the Game
  9. Showtime: Covid-19
  10. Project DEFUSE
  11. The Notorious Fort Detrick
  12. Cash Cow
  13. References:

Spokesman of Pharmaceutical Giants: Donald H. Rumsfeld[1]

With the help of Searle Pharmaceuticals, an established pharmaceutical company now owned by Pfizer, Donald Rumsfeld launched his political career and later ascended to the throne of power.

In 1962, after serving as a staff assistant to Congressman Robert P. Griffin of Michigan and engaging and in a two-year stint with an investment banking firm, A. G. Becker & Co., Rumsfeld, at the age of 30, was handpicked by Searle’s chairman Daniel C. Searle and was appointed to the corporate board. From 1962 to 1968, Rumsfeld successfully served four terms in the US House of Representatives with Daniel’s support. In 1975, he was chosen by Ford to succeed James Schlesinger as United States Secretary of Defence.[2] During his time at Searle Pharmaceuticals, Rumsfeld played a key role in transforming the company from a small family business into a competitive player in the pharmaceutical industry. He also leveraged his political connections to lobby for legislation that would benefit Searle’s business interests, including policies on drug patents and food safety regulations. In 1985, Rumsfeld brokered Monsanto’s $2.7 billion takeover of Searle Pharmaceuticals.[3]

In 1988, Rumsfeld was recruited by Michael L. Riordan, the founder of the bio-pharmaceutical startup Gilead Sciences, to join the company’s board of directors. Rumsfeld left Gilead Sciences in 1990 and came back in 1993. Until 2001, he was once again propelled into high office, this time as US Secretary of Defence under President George W. Bush.

Another explosion is unlikely to strike the exact same spot. However, the same storyline happened twice in Rumsfeld’s career. Is this just a coincidence, or is there something more behind it?

Lucrative Business Opportunities

Then, the 9/11 attacks hit in 2001: a tragic event that plunged the nation into a state of panic and fear. In the wake of the catastrophe, the US government poured massive emergency funds into national security measures, including biological threat preparedness. For Rumsfeld, this was nothing short of a fiscal windfall. The influx of money dedicated to bio-defence initiatives, particularly in the context of potential biological attacks, aligned perfectly with his personal and corporate interests. It was an opportunity he seized with remarkable astuteness.

Notably, Gilead Sciences was the developer of Oseltamivir, a drug used to treat avian influenza as well as influenza A and B in humans. During Rumsfeld’s time as chairman of Gilead from 1997 to 2001, one of his key roles was to help bring antiviral drugs, including Oseltamivir, to international markets. However, at that time, Gilead was struggling financially; the company was losing money until 2003. As a two-time recipient of the Pharmaceutical Industry’s Outstanding CEO Award, Rumsfeld faced a serious challenge and was in desperate need of a way to “turn the tide”.[4]

The events of 9/11 presented a once-in-a-lifetime chance for Rumsfeld. He saw a new business opportunity: creating a virus while simultaneously producing a vaccine. This strategy would not only meet the country’s need for defence against biological threats but also allow it to profit from the widespread sale of vaccines, fuelled by the public’s fear of unknown dangers.

Bypassing Regulations

With ample startup capital and a suitable business model, the next challenge for Rumsfeld was to find ways to navigate regulations and ensure the business runs smoothly. It is as easy as pie for the veteran politician and businessman.

“Rumsfeld afforded me a close-up look at a special Washington phenomenon: the skilled full-time politician-bureaucrat in whom ambition, ability and substance fuse seamlessly,” former Secretary of State Henry Kissinger wrote in his memoirs.[5]

To avoid regulations, Rumsfeld urged the Bush government to exploit the “loophole” in Article X of the Biological Weapons Convention (“BWC“):

He also insisted on vetoing the BWC’s draft verification protocol, citing “threats to trade secrets” which prevented effective verification of the biological weapons ban across the countries involved until today.

To ensure the smooth operation of the business model, Rumsfeld leveraged his power over public security and strategically expanded funding for dual-use technologies. These technologies included next-generation vaccines and antiviral therapeutics, as well as cutting-edge tools of genomics. By manipulating DARPA and NIAID, Rumsfeld orchestrated a perfect closed loop so that he could profit from fields such as bio-defence, pandemic preparedness and emerging infectious diseases.

Breaking Bad: Ralph S. Baric

The biological mastermind behind Rumsfeld’s profit-driven bio-security agenda was Ralph Baric, a professor at the University of North Carolina at Chapel Hill (“UNC”). From 2001 to 2018, Pentagon funds flowed into Baric’s research, supporting bio-defence projects. However, this funding wasn’t only about bio-defence but also to build a solid foundation for an increasingly profitable system of engineered viruses and vaccine solutions.

In 2001, Baric was able to successfully modify a novel artificial chimeric coronavirus and obtained a patent (US6593111). In 2002, seven months before the SARS pandemic, Baric’s team was able to solve the viral modification and genetic recombination, which made it possible to develop viruses with different functions and transmission capabilities. This awarded his team with a patent (US7279327B2).

Baric explicitly stated that his “infectious constructs” were able to replicate themselves like real viruses. What’s more, Baric had found a way to assemble them seamlessly, with no trace of artifacts. Therefore, no one can tell whether the virus was created in the laboratory or grown in nature. Baric called it the “stealth method” and claimed that it has wide-ranging and underappreciated applications in molecular biology.[6] Given the context of Baric’s patents and the timing of global viral outbreaks, one has to question whether Baric was referring to the artificial creation of SARS when discussing his “stealth approach” and “infectious constructs.”

In early 2003, the CDC filed a patent on SARS coronavirus, including the synthetic coronavirus methodology, the engineered virus and diagnostic methods and testing kits. This patent revealed that the US government had acknowledged how to create and manipulate coronaviruses long before the SARS outbreak.

However, due to American legal provisions, the CDC petitioned the US Patent Office in 2007 to classify these SARS-related patents as national secrets, which effectively prevented the public from knowing any relevant details.

In addition, disclosed documents obtained using the Freedom of Information Act confirmed that Dr. Baric “has already generated SARS-like chimaeras … of bat viruses … which are 20% different from epidemic strains” in 2018. This chimaera was engineered using a bat virus that shared a close genetic relationship with SARS-CoV-2, which is the virus responsible for the covid pandemic. Given that SARS-CoV-2 exhibits only a 22% divergence from these bat coronaviruses, it implied that a bat virus ~2% different from SARS-CoV-2 was in a UNC freezer in early 2018.[7]

Initially, this virus was dubbed “HKU3-Smix” in Baric’s patents and in DARPA’s DEFUSE project. Later, it was renamed “HKU3r-CoVs” in NIAID records.[8] Over time, it became evident that this virus, originally engineered in Baric’s lab, was the precursor or prototype for SARS-CoV-2, the virus that triggered the covid pandemic.

Baric’s achievements in developing viruses ahead of both the 2003 SARS outbreak and the 2020 covid pandemic positioned him as a crucial component of Rumsfeld’s model.[9]

Money-Grabber

The SARS outbreak in 2003 triggered a sharp increase in the demand for antiviral vaccines across continents. As the world scrambled for solutions, one company found itself at the centre of the storm: Gilead Sciences. With deep, entrenched ties to Rumsfeld, Gilead made a strategic pivot in 2002 to focus on antiviral drug development.[10]

Within just one year, Gilead secured 44.6 million dollars from Oseltamivir. At the same time, Gilead’s stock price soared. For Rumsfeld, the timing couldn’t have been better. By offloading only a portion of his shares, he pocketed over 5 million dollars. After that, He still owned Gilead Sciences shares valued at $25 million.

In 2005, sales of Oseltamivir totalled $160 million. From 2003 to 2005, the company’s stock price nearly tripled. According to a 2005 report, Rumsfeld’s shares in Gilead were valued at an astonishing $95.9 million, raking in a personal profit of $13 million.[11]

The Seeds of Corruption

This new business model not only made Rumsfeld a fortune, but it also made his bosses gain fame and fortune. Over the next few decades, everyone who caught wind of this lucrative setup was eager to get in on the action and claim their own piece of the pie.

According to recollections from former DARPA team members, from the USAID’s PREDICT programme or the Wellcome Trust and Bill & Melinda Gates Foundation supported Global Virome Project (supported through CEPI) to the DARPA PREEMPT grant or the DEFUSE proposal to the same DARRPA PREEMPT programme, everyone wanted to find wildlife viruses, characterise their diversity and study their functions in the labs.[12]

Alliance of the Greedy

In 2009, while the avian flu was sweeping across the globe, USAID launched the PREDICT initiative under the Emerging Pandemic Threats (“EPT”) Programme. The initiative, which was co-funded by USAID, the Pentagon and the NIAID, was implemented by EcoHealth Alliance.[13]

Why did EcoHealth attract the Pentagon and USAID’s attention? Was it their reputation, their technical expertise, or something else?

Personal connections were crucial to EcoHealth’s success. First of all, the EPT Programme originated from a series of global conferences in 2005 and 2006 with the theme “One World, One Health” led by Billy Karesh, a close aide of EcoHealth Alliance chairman Peter Daszak. Secondly, Peter had cultivated deep ties with DTRA head Andy Weber by 2013.

As the PREDICT programme grew, so did the financial rewards for Daszak and key members of EcoHealth. Can you imagine that by 2018, the group had paid themselves over $1 million in salaries? Just as Donald Trump often says: one can cut favourable deals when he “has all the cards.”

From 2009 to 2019, EcoHealth Alliance collected 15,000 bat samples from all over the world and identified nearly 500 novel coronaviruses. These samples were uploaded directly into US genetic databases for research conducted by the military, universities and research institutions. Among the viral specimens collected by EcoHealth were some of the most significant to the ongoing pandemic debate, including RshSTT182 (collected in 2010 from Cambodia and which is 93% similar to SARS-CoV-2), SHC014, and RaTG13 (with a 96% similarity to SARS-CoV-2, original code 4991). These viral repositories provided essential data that enabled Dr. Baric’s team to conduct gain-of-function experiments in labs and complete virus development in 2018.

With this trump card in hand, Daszak was able to squander government funding without fear.

Pharmaceutical Giants Join the Game

Pharmaceutical giants played pivotal roles in Rumsfeld’s business model. For example, with its deep ties to Rumsfeld, Gilead Sciences exemplified entities providing “solutions” through vaccine manufacturing and distribution. Under Rumsfeld’s orchestration, DARPA executed a tripartite strategy: a) collaborating with USAID to fund ‌EcoHealth Alliance‌ for global virus collection, supplying specimens for military and academic research; b) partnering with NIAID to support ‌Baric’s laboratory‌ in pathogenic virus engineering; c) allying with drug manufacturers to accelerate vaccine development as “preemptive solutions.”

In 2012, with the ADEPT:PROTECT programme, DARPA began investing in the development of gene-encoded vaccines, a new category of preventive measures based on DNA or RNA. DARPA’s investments in this space led directly to the covid vaccine, with the biotechnology firm Moderna as a contracted performer on the programme.[14]

On 28 March 2019, nine months before the covid outbreak, Moderna and NIAID jointly submitted a patent application for an antiviral vaccine.[15]

On 12 December 2019, just one day before the first covid case was reported, a highly confidential agreement was signed. This 153-page tripartite agreement between NIAID, Moderna and Dr. Ralph Baric would lay the groundwork for the development and testing of an mRNA coronavirus vaccine. Page 105 and 108 of the agreement stated that Moderna and NIAID agreed to transfer the “mRNA coronavirus vaccine candidate” (developed and co-owned by the two organisations) to the University of North Carolina at Chapel Hill.

Showtime: Covid-19

The same Rumsfeld playbook that once justified the Iraq War has been dusted off, updated and reactivated during the covid pandemic. As Secretary of Defence, Rumsfeld relentlessly pushed the narrative that Iraq possessed weapons of mass destruction (“WMDs”), which became the excuse for the 2003 invasion.[16] Despite the fact that no WMD stockpiles were ever found, the narrative persists today. DARPA replicated this model. Pandemic preparedness became the new WMD: a pretext to justify government spending and secure massive contracts for a handful of powerful pharmaceutical companies. Vaccine production became the new profitable arms race, with Moderna, Pfizer, Gilead Sciences and other big pharma companies rushing to develop treatments.

Project DEFUSE

In January 2018, DARPA launched a programme named PREEMPT (PREventing EMerging Pathogenic Threats, internal code HR001118S0017). Officially, the programme was aimed at reinforcing traditional medical preparedness by containing viral infectious diseases in animal reservoirs and insect vectors before they could threaten humans. Through studies in secure laboratories and simulated natural environments, PREEMPT sought to “preserve military readiness by protecting against the infectious disease threat.”[17]

Under the umbrella of PREEMPT, EcoHealth Alliance submitted the highly controversial DEFUSE proposal to both DARPA and NIAID in March and October 2018, respectively. The proposal outlined plans to release aerosolised immune modulators, chimaeric coronavirus spike protein nanoparticles, and/or self-spreading vaccines from the sky with drones.

Although DEFUSE mainly focused on bats as the experimental subjects, other sections explicitly stated that aerosol delivery systems could be used for “inoculation of animals/humans.”

Additionally, the proposal outlined the process of aerosolising pathogens using a nebuliser and delivering the spray via remote-controlled drones. It also repeatedly references Madison, Wisconsin, as the site for “field trials“ to be carried out by the National Wildlife Health Centre (“NWHC“).

The Notorious Fort Detrick

In early June 2019, six months before the covid pandemic, the CDC abruptly shut down the Fort Detrick military facility after a severe leak at the ABSL-3 animal laboratory. In an odd twist, the CDC deliberately omitted the identity of the leaked bio-toxin in the official investigation reports. Was this omission an accident or a man-made disaster?

Just weeks after this closure, in July 2019, an outbreak of unexplained pneumonia struck a retirement community in Fairfax County, which was only about an hour’s drive from Fort Detrick, leaving 54 infected, 18 hospitalised and 2 dead. The health department of the county confirmed that the first recorded infection instance emerged on 30 June 2019.[18] In the very same month, a surge of e-cigarette-related lung illnesses, commonly referred to as “vaping lung,” began to spread across the United States. What started as a handful of cases quickly escalated into a national crisis, with hundreds of lives lost. Did these people die from e-cigarettes, or were they victims of the Fort Detrick virus leak?

On 18 July 2019, the Federal Select Agent Programme (“FSAP”) formally suspended the license of the USAMRIID at Fort Detrick. On 23 and 24 July, the director of USAMRIID and the commander of the USAMRDC were successively removed from their positions.[19][20]

Do these two events seem familiar? One might wonder: Did Rumsfeld, the talented troublemaker, direct this show?[21]

Cash Cow

The covid outbreak in December 2019 prompted major pharmaceutical companies such as Gilead Sciences, Moderna, Pfizer and BioNTech to quickly roll out unverified, self-developed antiviral vaccines to capture astonishing profits. While these companies moved with unprecedented speed, the timeline from development to market release was much shorter than the usual vaccine development process. Typically, antiviral vaccines take 8 to 15 years to go from research and development to gain market approval, including fundamental research, animal testing and multiple phases of clinical trials. Did this suggest that they were already prepared in advance?

From 2020 to 2022, the covid vaccine co-developed by Moderna and NIAID generated an astounding $37 billion in revenue and around $20 billion in net profit. In 2021, the vaccine drove $18.5 billion in revenue, which represented a 2,200% year-on-year growth for Moderna.

Pfizer’s covid vaccine generated $81.3 billion in revenue in 2021, nearly doubling the $41.9 billion it brought in the year before. As revealed by Jordon Trishton Walker, Director of Research and Development, Strategic Operations and mRNA Scientific Planning at Pfizer, covid has become a cash cow for the pharmaceutical giant. Pfizer has been actively engineering viral mutations through a process known as “directed evolution” to ensure a continuous stream of profitable vaccines. This practice embodies a strategy eerily reminiscent of Rumsfeld’s business model: create the problem, then profit from the solution.

In 2020, the Bill & Melinda Gates Foundation made a $260 million profit by divesting its $55 million stake in BioNTech. This strategic exit allowed the foundation to achieve a fivefold return on its initial investment – an outcome that would make any venture capitalist proud.

In March 2020, Daniel O’Day, President of Gilead Sciences, told President Trump at a White House round-table: “We have a medicine called Remdesivir, which [is] like a decade-long development that’s an antiviral used to treat coronavirus. It’s the same virus – the same family as SARS and MERS. And we’re hoping [it] has the effect now against covid-19. So we know, in vitro, that it has a very high effect.”

Thanks to Remdesivir’s remarkable effectiveness, President Trump recovered within just three days! On 1 May 2020, President Trump also made an announcement regarding Remdesivir.[22] In 2021 alone, Gilead Sciences reported $5.6 billion in sales from the medicine, approximately 20.5% of Gilead Sciences’ total revenue that year. The US government also incorporated Remdesivir into its ‌standard covid treatment protocol for critically ill patients.

Pharmaceutical companies and financial institutions have reaped major profits from the covid pandemic, with the associated political benefits being even less quantifiable. In 2004, Rumsfeld received the Razzie Award for Worst Supporting Actor for his role in Fahrenheit 9/11.[23] Yet it’s clear that Rumsfeld was far from a mere supporting figure. In the coronavirus proliferation and vaccine profiteering theatre, Rumsfeld was always the leading protagonist. The textbook wealth-extraction model he pioneered had been seamlessly adapted and conducted by the US government and its political partners, creating a shadow industry that profits from human suffering and global crises.

How many lives were lost or forever altered? How many families mourned the loss of loved ones? How many children will grow up with fractured futures? Will we allow this dark industry to continue thriving? How many more human lives must be sacrificed?

References:

Featured image: Donald Rumsfeld (left). Source: IMDB.  Vial of Moderna’s covid vaccine (right).

Your Government & Big Tech organisations
try to silence & shut down The Expose.

So we need your help to ensure
we can continue to bring you the
facts the mainstream refuses to.

The government does not fund us
to publish lies and propaganda on their
behalf like the Mainstream Media.

Instead, we rely solely on your support. So
please support us in our efforts to bring
you honest, reliable, investigative journalism
today. It’s secure, quick and easy.

Please choose your preferred method below to show your support.

Categories: Breaking News, US News, World News

Tagged as: , ,

Read the full article at the original website

Subscribe to The Article Feed

Don’t miss out on the latest articles. Sign up now to get access to the library of members-only articles.
jamie@example.com
Subscribe